The Antidepressant Effects of rTMS After Ischemic Stroke

Not yet recruiting

Phase N/A Results N/A

Summary of Purpose

This is a multicenter, randomized, double-blind, placebo-controlled trial aims to assess the effectiveness of rTMS in treating depression after basal ganglia ischemic stroke and to examine whether such effects are related to restoration of white matter integrity.Sixty-six participants will be recruited from three centers and randomized with a 1:1 ratio to receive active rTMS treatment or sham rTMS treatment in...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 May 2017.

1 Jun 2017 1 May 2017 31 May 2020 31 May 2020 1 Jan 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

Not available

Contacts